Central sleep apnoea device increases mortality in heart failure
Adaptive servo-ventilation (ASV) therapy increases mortality and should not be used to treat central sleep apnoea in heart failure patients with reduced ejection fraction, the SERVE-HF trial shows.
Sep 1, 2015
0
10